MedImmune Biologics, Incorporated Contract Details

Defense contract under the Defense Logistics Agency awarded to MedImmune Biologics, Incorporated on 4/11/2016.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.

The contract language is EXACTLY as it appears on the official U.S. DoD website ( unless otherwise noted.

Contractor: MedImmune Biologics, Incorporated
Department: Defense Logistics Agency
Awarded: 4/11/2016

MedImmune Biologics Inc., Gaithersburg, Maryland, has been awarded a maximum $47,600,000 modification (P0001) exercising the first one-year option period of a one-year base contract (SPE2DP-15-D-0003) with one one-year option period for influenza vaccine. This is a firm-fixed-price contract. Locations of performance are Maryland and Pennsylvania, with a June 5, 2017, performance completion date. Using military services are Army, Navy, Air Force and Marine Corps. Type of appropriation is fiscal 2016 through fiscal 2017 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania.

Total Contract Value: $47,600,000

View all contracts that include "MedImmune Biologics, Incorporated" in the MiC database.